Clinical trial
Efficacy of Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity as a Biomarker of Myocardial Damage in Patients With Rheumatoid Arthritis With Severe Activity.
NCT04056039 is registered in ClinicalTrials.gov with Hospital Central "Dr. Ignacio Morones Prieto" as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity as a Biomarker of Myocardial Damage in Patients With Rheumatoid Arthritis With Severe Activity.
- Lead sponsor
- Hospital Central "Dr. Ignacio Morones Prieto"
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 14, 2018
- Completion date
- June 30, 2019
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.